Linagliptin
Linagliptin is an orally active DPP4 inhibitor used to improve glucose tolerance in diabetic rodent models.
- The description claims that sitagliptin improves glucose tolerance and exhibits efficacy in diabetic rodent models.
AI Readiness
Good foundation, but some important product data is still missing.
66%